News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IMRIS To Hold First Quarter 2014 Results Conference Call And 2014 Annual Meeting Of Shareholders


5/8/2014 10:02:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WINNIPEG, May 8, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)

First Quarter 2014 Earnings ReleaseMay 13, 2014
Conference Call and WebcastMay 13, 2014 4:00 pm ET
Hosted by Jay D. Miller, President and Chief Executive Officer;
Kelly McNeill, Executive Vice President, Finance & CFO
Participant Numbers 416-644-3415 or 1-877-974-0445
Conference Call ID Number 4681231

A question and answer session for analysts and institutional investors will follow management's presentation. A taped rebroadcast will be available to listeners until 12 a.m. on May 20, 2014. To access the rebroadcast from Canada please call 416-640-1917 or 1-877-289-8525. From the U.S., please call 1-303-590-3030 or 1-800-406-7325. Enter access code 4681231.

Annual General MeetingMay 13, 2013 6:00 pm ET
Hosted by David Graves, Chairman;
Jay D. Miller, President and Chief Executive Officer;
Kelly McNeill, Executive Vice President, Finance & CFO
Location Grand Hotel Toronto
225 Jarvis Street
Toronto, Ontario

Following the formal part of the meeting, management will host a question and answer session. A live audio webcast of the meeting will be available on the company's website at www.imris.com.

About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular, spinal and cerebrovascular markets and have been selected by 57 leading medical institutions around the world. For more information, visit www.imris.com.

SOURCE IMRIS Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
IMRIS
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES